Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.16 USD | +0.88% | +1.28% | +6.80% |
May. 29 | UBS Adjusts DuPont de Nemours Price Target to $98 From $93, Maintains Buy Rating | MT |
May. 28 | DuPont's Breakup Plan Holds Logic Amid Disadvantages, BofA Says | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Sales forecast by analysts have been recently revised upwards.
- For the past twelve months, EPS forecast has been revised upwards.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With an expected P/E ratio at 31.32 and 23.04 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.24 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.80% | 34.35B | C | ||
-1.05% | 74.34B | B | ||
-0.76% | 46.86B | A- | ||
+9.37% | 18.1B | B | ||
+12.81% | 11.92B | A- | ||
-3.01% | 10.43B | - | ||
-20.72% | 10.33B | B | ||
-1.35% | 9.04B | A- | ||
-11.01% | 7.84B | C- | ||
-3.85% | 7.52B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DD Stock
- Ratings DuPont de Nemours, Inc.